image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
fba7d30510659b049ef7201bd5022aa1e35f5c858ae96496aff631e6cc2d654e.png | complex | <table><tr><td>Key challenges</td><td>Solutions</td><td>Future implications</td></tr><tr><td colspan="3">1) Identification of centres willing/able to participate in the study</td></tr><tr><td>• Identifying centres with interest/capacity to participate in research and the correct people to discuss participation wi... |
2f062a70b091f54d8289c9342e834672ce0a02b5026d812349e9692f38af4269.png | complex | <table><tr><td></td><td colspan="2">Overall survival</td><td colspan="2">Disease specific survival</td></tr><tr><td>Covariate</td><td>Hazard ratio (95% CI)</td><td>p value</td><td>Hazard ratio (95% CI)</td><td>p value</td></tr><tr><td>Age</td><td>0.99 (0.97-1.01)</td><td>0.26</td><td>0.99 (097–1.01)</td><td>0.16<... |
88233c77798cc8510603047cb8479353891423e55041c112a400431bfdc51b0b.png | simple | <table><tr><td>Case</td><td>Case summary</td><td>Examination type</td><td>Performing department</td><td>Allegation</td></tr><tr><td>1</td><td>Middle-aged female presented with calf pain. Ultrasound study reported to be negative. Patient had fatal pulmonary embolism. (2012 WL 1100657 [Ohio App. 7 Dist])</td><td>DVT</td>... |
21c082d40317d7c31ab868d2ed39bc74669ac2543c4a6f62c143de42796685f6.png | complex | <table><tr><td rowspan="2"><i>Variables</i></td><td><i>Utilization </i><i>(HP visits)</i></td><td> </td><td rowspan="2"><i>Crude OR </i><i>(95% </i><i>CI)</i></td><td rowspan="2"><i>Adjusted OR </i><i>(95% </i><i>CI)</i></td></tr><tr><td>Yes</td><td>No</td></tr><tr><td>Mothers’ occupation</td><td> </td><td> </td>... |
ad36c9a628248746636c2e216e8dc3ad934ea7e5317eb4d920091cf7cd90edb1.png | complex | <table><tr><td rowspan="2">Group</td><td rowspan="2">n</td><td rowspan="2">Before Treatment</td><td rowspan="2">After Treatment</td><td colspan="2">Comparison</td></tr><tr><td>F</td><td>P</td></tr><tr><td>Moxibustion Group</td><td>15</td><td>28.27 ± 6.64</td><td>9.00 ± 4.05</td><td>417.009</td><td><0.001</... |
6e4d63941c5fe1e762d05074a65b4b99174b48537c4e14c22a7b834d4fa064fd.png | simple | <table><tr><td></td><td>ARDS patients</td><td>Age- and sex-matched reference values</td><td><i>P</i> value</td></tr><tr><td></td><td>Mean (SD)</td><td>Mean (SD)</td><td></td></tr><tr><td>EQ5D index at 6 months</td><td></td><td></td><td></td></tr><tr><td>Patients under 65</td><td>0.55 (0.37)</td><td>0.85 (0.06)</td><td>... |
b7c693bc89e255d2cb78e3c21e094a45cb7a3a2e0539aea940185027054294e0.png | complex | <table><tr><td></td><td>Total sample</td><td>Respondents</td><td>Non-respondents</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>N</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td><td>P-value*</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><i>Male... |
fdabdf00e092e1980317bede17509cca0a127932486e4bbd8d7acbe26289a399.png | simple | <table><tr><td>Variable</td><td>25th percentile</td><td>50th percentile</td><td>75th percentile</td><td>Standard deviation</td></tr><tr><td>GC</td><td>0.298</td><td>0.318</td><td>0.353</td><td>0.041</td></tr><tr><td>RHI</td><td>0.218</td><td>0.233</td><td>0.260</td><td>0.033</td></tr><tr><td>80/20 ratio</td><td>5.550</... |
13a463b899d6457181b9a2fe30fe807b339e0c7b62c5a4838624e8422f4e676f.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">2016</td><td colspan="4">2017</td><td colspan="4">2018</td><td colspan="4">2019</td></tr><tr><td>Q2</td><td>Q3</td><td>Q4</td><td>Q1</td><td>Q2</td><td>Q3</td><td>Q4</td><td>Q1</td><td>Q2</td><td>Q3</td><td>Q4</td><td>Q1</td><td>Q2</td><td>Q3</td><td>Q4</td></tr><tr><td>P... |
ececf72ab574ef6b8c69da349f8dffb2de47d7e5d157e748bc929d5f21705847.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">I</td><td colspan="2">II</td><td rowspan="2">% change</td><td rowspan="2">Cohen's <i>d</i></td></tr><tr><td>Mean ± SD</td><td>(95% CI)</td><td>Mean ± SD</td><td>(95% CI)</td></tr><tr><td><i>Lower body WAnT</i></td><td> </td><td> </td><td> </td><td> </td><td> </... |
ffd6f5f4203f7bba6d6912252207d2e528889662c181d07b7b0164f138b75bbf.png | simple | <table><tr><td>Trait</td><td>OR (95% CI)</td><td><i>p</i></td></tr><tr><td>Total serum IgE</td><td>1.60 (1.24, 2.07)</td><td>< 0.0001</td></tr><tr><td>Atopy</td><td>3.09 (1.39, 6.87)</td><td>0.006</td></tr><tr><td>Food allergen test positive</td><td>2.04 (0.99, 4.20)</td><td>0.053</td></tr><tr><td>Eosinophilia</td><... |
6b5ca4b9f6f7ed514611ee1b109381980fec7a327b66022651e0844a97392163.png | complex | <table><tr><td></td><td colspan="4">Controls</td><td colspan="4">Patients</td></tr><tr><td></td><td>Scene</td><td>Object</td><td>Face</td><td>Total</td><td>Scene</td><td>Object</td><td>Face</td><td>Total</td></tr><tr><td colspan="9">(A) MEAN ERROR RATE (PERCENTAGE ERROR)</td></tr><tr><td>Color</td><td>0.67</td><td>0.50... |
4b7201a730a2f78c8694e25eba1877f025887cebabb3dd56e104f52b6ac3b8a5.png | simple | <table><tr><td>Diets</td><td>Intestine</td><td>Liver</td><td>Muscle</td><td>Brain</td></tr><tr><td>HD</td><td></td><td></td><td></td><td></td></tr><tr><td>LD</td><td></td><td></td><td></td><td><i>fabp7b</i></td></tr><tr><td>LND</td><td><i>fabp1b.1, fabp7b</i></td><td></td><td><i>fabp7a</i></td><td></td></tr><tr><td>LFD... |
555b9a4e8fbebe678bf40c222641488063ab1ba992a52de233d9e51ecb007b6d.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>OR</td><td>95% CI for OR</td><td><i>p</i></td><td>OR</td><td>95% CI for OR</td><td><i>P</i></td></tr><tr><td colspan="7">Total cholesterol: high (<i>n</i> = 93) vs normal (<i>n</i> = 178)</td><... |
3e362cd09d5bf9c1a6324d80a428c86507afaeeeef86bfd05a25cb8fd216c77a.png | complex | <table><tr><td> </td><td colspan="3">Midwives</td><td colspan="3">Child health nurses</td><td colspan="3">Dental hygienists/dental nurses</td></tr><tr><td> </td><td colspan="2">Raising the topic with more than half or all pregnant women (%)</td><td>Wilcoxon Signed Rank Test</td><td colspan="2">Raising the topic with mo... |
a97ccb600637da16d04470e93201dc4c3c39a2057b8ced35371318540372849c.png | complex | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2">No. patients(%)</td><td colspan="2">ZC3H15 immunoreactivity*</td><td rowspan="2">P value</td></tr><tr><td>High</td><td>Low</td></tr><tr><td colspan="5">Gender</td></tr><tr><td> Male</td><td>230(88.12)</td><td>125</td><td>105</td><td>0.1017</td></tr><tr><td>... |
15ab7187da7b3cecdf245a36453c5258fe26bfb6f048f8a6acdb7ece3b63d90e.png | simple | <table><tr><td></td><td>Severe (<i>n</i> = 12)</td><td>Mild (<i>n</i> = 5)</td><td></td></tr><tr><td>Birth Weight (g)</td><td>2500(2400–3000)<sup>a</sup></td><td>3100 (3000–3600)</td><td><i>p</i> = 0.04</td></tr><tr><td>Day of illness at hospital presentation</td><td>2.5 (2–3.5)</td><td>5 (5–5)<... |
120d18f7d340e1719d202f0152263fa72e8cf64cfde12d60840ce096335923b7.png | complex | <table><tr><td rowspan="2">HLA alleles</td><td rowspan="2">Risk allele (RA)</td><td colspan="3">Risk allele frequency</td><td rowspan="2"><i>P</i>-value</td><td rowspan="2">OR</td><td rowspan="2">CD groups</td></tr><tr><td>Indian</td><td>African</td><td>European</td></tr><tr><td rowspan="2">HLA-DQ2.2 (rs2395182)</td><t... |
3cdb98a362cf19819f349b2fb1628f00aaa8ab0fff94d52809e860456a26a478.png | simple | <table><tr><td>Outcomes</td><td>Conventional period<i>n</i> = 79 (%)</td><td>MALDI-TOF period<i>n</i> = 75 (%)</td><td><i>P</i> Value†</td></tr><tr><td>Time to pathogen identification (hours)</td><td>86.9 ± 30.4</td><td>62.5 ± 23.1</td><td>< 0.001</td></tr><tr><td>Time to effective therapy (hours)</t... |
03fff6c3446a1a5275044e9b919382e70331fbbaa8fa7b75a3d7e35ee283a721.png | simple | <table><tr><td>NaHS (μmol/L)</td><td>5′- GMP (μmol/L)</td><td><i>P</i></td></tr><tr><td>Basal (0)</td><td>0.45 ± 0.08</td><td></td></tr><tr><td>3</td><td>0.31 ± 0.09</td><td>0.27</td></tr><tr><td>50</td><td>0.15 ± 0.04 **</td><td>0.01</td></tr><tr><td>300</td><td>0.21 ± 0.06*</td><td... |
c5ae0bd0624b411f6e3c50a7189468e9b02e0394a7b8a4abeb74b181f30784c9.png | complex | <table><tr><td>Mouse primers</td><td></td><td>Oligonucleotide sequences (5’−3’)</td></tr><tr><td rowspan="2"><i>Aldh1a1</i><sup>-/-</sup></td><td>Forward</td><td>TGAGCAAATCCTCCACAGCCCTGTTC</td></tr><tr><td>Reverse</td><td>CTGCTAAAGCGCATGCTCCAGACTG</td></tr><tr><td rowspan="2"><i>Aldh1a3</i> flox</td><... |
9262d100e3a03a6fd3d2bdc7ecf8aad302681e015dcb7f1094242197a6f9a2d5.png | complex | <table><tr><td rowspan="2">Survey items</td><td rowspan="2">Overall (<i>n</i>=48)</td><td colspan="2">Completely achieved ILP goals and objectives</td></tr><tr><td>‘No’ (<i>n</i>=25)</td><td>‘Yes’ (<i>n</i>=23)</td></tr><tr><td colspan="4">ILP helpful in structuring ACE learning objectives (Rate... |
5d2470e477259cc6ca13f19d8ef253df91de766ab97ae58113a5c2e1b1af2fca.png | simple | <table><tr><td>Variable</td><td>CF1</td><td>CF2</td><td>CF3</td></tr><tr><td>As</td><td>−0.06</td><td>0.00</td><td>0.95</td></tr><tr><td>Cd</td><td>0.02</td><td>0.85</td><td>0.16</td></tr><tr><td>Cr</td><td>0.86</td><td>0.12</td><td>−0.13</td></tr><tr><td>Cu</td><td>0.83</td><td>0.09</td><td>−0.30</td... |
2860e932ddd053962e7712fb4a835cf98cee309bd17b43142434a96c6984c1a3.png | simple | <table><tr><td>Variable</td><td>HE group (<i>n =</i> 58)</td><td>Control group (<i>n =</i> 59)</td><td><i>P</i>-value</td></tr><tr><td>Historical information</td><td></td><td></td><td></td></tr><tr><td> Esophageal varices</td><td>60%</td><td>66%</td><td>0.518</td></tr><tr><td> Variceal bleeding</td><td>21%</td><td>24%<... |
4d1b2bf070929e030becc07c336b6dff379d5d9cd467112a2b09b69de76173d4.png | complex | <table><tr><td rowspan="2">Male</td><td rowspan="2">Control (mg/kg)</td><td colspan="3"><i>Alstonia scholaris</i> Extract Dose (mg/kg)</td></tr><tr><td>250</td><td>500</td><td>1000</td></tr><tr><td>TP (g/L)</td><td>67.21 ± 3.34</td><td>65.34 ± 4.5</td><td>70.32 ± 2.3</td><td>69.73 ± 1.52</td></tr><t... |
311fa422b200a2760751b86532b9268ee8d589543277ff72ec895aff139d9555.png | simple | <table><tr><td>Variable</td><td>n</td><td>%</td></tr><tr><td>Surgical approach</td><td> </td><td> </td></tr><tr><td> Laparoscopic, completely closed</td><td>20</td><td>90</td></tr><tr><td> Hand-assisted laparoscopic</td><td>1</td><td>4.5</td></tr><tr><td> Lap converted to open</td><td>1</td><td>4.5</td></tr><tr><td>No.... |
508c7ff686544f19782ad2b10bd4ca66a1effa420824eeb95808fcc38c71bf18.png | simple | <table><tr><td>Protein 1</td><td>Protein 2</td><td>VAST</td><td>DALI</td><td>CE</td><td>FATCAT</td><td>Yang & Tung's</td><td>de Brevern et al.'s</td><td>Our SA</td></tr><tr><td>1fxia</td><td>1ubq</td><td>48(2.10)</td><td>60(2.60)</td><td>64(3.80)</td><td>63(3.01)</td><td>59(2.76)</td><td>76(2.89)</td><td>58(2.64)</... |
f63de1d6f464171fdab77976293dc4ca907ad1d5bd220f195ea94c61b0526cd8.png | simple | <table><tr><td>ORF Clusters features</td><td>MFL x MHP*</td><td>MFL x MHR*</td><td>MFL x MHP x MHR*</td></tr><tr><td>OCs 100% conserved</td><td>44</td><td>17</td><td>12</td></tr><tr><td>OCs Partially conserved</td><td>44</td><td>35</td><td>33</td></tr><tr><td>OCs Without conservation</td><td>29</td><td>62</td><td>-</td... |
569bda90e5779a53345aef42f2ceda715f9a4d477aea122c57a0e46e4ad1932e.png | simple | <table><tr><td>Conceptualization</td><td>Description</td></tr><tr><td>Revolution</td><td>• Health’s increasing role in foreign policy is transformative of the health-foreign policy nexus• Health collapses the traditional distinction between high and low politics and creates a new political space in wh... |
fab5d5bf24682538b3e1b730f299aec0ccc2fc468d971025cfd9ba49fcd52605.png | complex | <table><tr><td></td><td>EU</td><td>Australia</td><td>Japan</td><td>WHO</td><td>Canada</td><td>Korea, India, Singapore, Malaysia</td></tr><tr><td>Synonym</td><td>Biosimilars</td><td>Biosimilars</td><td>Follow-on Biologics</td><td>Similar Biotherapeutic Product</td><td>Subsequent Entry Biologic</td><td>Biosimilars</td></... |
a673e609cd362ea388a6f7a511c64e5e24bf611c89acfb5db8aa0f46de154954.png | complex | <table><tr><td colspan="7">Pharmacovigilance area of interest</td></tr><tr><td>Activity type</td><td>Adverse events</td><td>Counterfeit drugs</td><td>Drug quality assurance</td><td>PV NOS</td><td>N/A</td><td>Total</td></tr><tr><td> Behaviour change communication</td><td></td><td>6 (85.7)</td><td>1 (14.3)</td><td></td><... |
f2cb5f8d06226bd847fe7bae835f83d323be25427adc330ad4e1111701cc64d7.png | simple | <table><tr><td>Schizophrenic Patient Variables</td><td>Values</td></tr><tr><td>Schizophrenia Severity</td><td>Severe/Other</td></tr><tr><td>Schizophrenia Heavy Alcohol Use</td><td>Yes/No</td></tr><tr><td>Schizophrenia Heavy Drug Use</td><td>Yes/No</td></tr><tr><td>Schizophrenia</td><td>Paranoid/Undiff</td></tr><tr><td>... |
6d9e3504e076aaec82c7896e50e2d9afdb7c0486ee4dbc9aa3847bec84e9f5c0.png | simple | <table><tr><td>Reads</td><td>Assembler</td><td>Contig</td><td>Scaffold</td><td>Transf</td><td>Untransf</td><td>Shared</td><td>Masked</td></tr><tr><td>Sim</td><td>allp</td><td>57</td><td>7</td><td>21</td><td>1</td><td>18</td><td>12</td></tr><tr><td>Sim</td><td>sga_m75</td><td>504</td><td>463</td><td>NA</td><td>NA</td><t... |
0d3d9b2703fc48780db3c9dd002a4bab3cbcd49e82fdfd321b2c71c653707ac5.png | simple | <table><tr><td></td><td>Total</td><td>Diagnosis</td><td>Clinical therapy & drug resistance</td><td>Case reports</td><td>Vaccine development</td><td>Epidemiology</td><td>Health education</td><td>Interventions and control</td><td>Others</td></tr><tr><td>HIV/AIDS</td><td>24025 (100%)</td><td>1229 (5.1%)</td><td>2706 (... |
6b9e9acdcc53d8ab492502d2b3c6b474b68b49bae0b79432202e6803a28486bb.png | simple | <table><tr><td>Variable</td><td></td><td>Control(<i>n </i>= 91)</td><td>Intervention(<i>n </i>= 92)</td></tr><tr><td>Age</td><td>mean (sd)</td><td>57.5 (15.1)</td><td>57.2 (17.0)</td></tr><tr><td>Gender</td><td>%</td><td>M: 61</td><td>M: 62</td></tr><tr><td>APACHE II</td><td>mean (sd)</td><td>19.5 (7.2)</td><td>19.4 (1... |
e8bfb91939513ac170e8f95010eeb466dd1189ad6e36f59aaa6f3114ebd39b30.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="4">Beclin 1 expression</td></tr><tr><td>All Cases</td><td>Low</td><td>High</td><td><i>p</i> Value</td></tr><tr><td>HER2 expression in total cases(41)</td><td></td><td></td><td></td><td>0.008</td></tr><tr><td>Negative</td><td>26</td><td>21(80.8%)</td><td>5(19.2%)</td>... |
2048b8b103ef988508a22ec60cbf83a2b636fb66f10d889e1466e0036ca3ac79.png | complex | <table><tr><td></td><td colspan="2">MALL expression</td><td></td></tr><tr><td></td><td>Negative</td><td>Positive</td><td></td></tr><tr><td>Variables</td><td>(<i>n</i> = 58)</td><td>(<i>n</i> = 145)</td><td><i>P</i>-value</td></tr><tr><td>Age (y)</td><td></td><td></td><td>0.319</td></tr><tr><td><65</td><td>20 (34.5)<... |
5ede25c0cbf8c819a42a0a4f772fb52d86c7d17671674ba9d6e3dc0ae8e997a0.png | simple | <table><tr><td>Group of patients</td><td>Survivin positive</td><td>Survivin negative</td><td>Total</td></tr><tr><td>COX-2 positive</td><td>55</td><td>8</td><td>63</td></tr><tr><td>COX-2 negative</td><td>15</td><td>15</td><td>30</td></tr><tr><td>Total</td><td>70</td><td>23</td><td>93</td></tr></table> |
37060d0c24564b3173b1b9dbfee58f29edee17dff415510d407f393c9ea7f580.png | simple | <table><tr><td>Characteristic</td><td>Healthy volunteers</td><td>RA patients</td></tr><tr><td></td><td>(N = 7)</td><td>(N = 10)</td></tr><tr><td>Age: mean (range)</td><td>56 (49–62)</td><td>63 (49–80)</td></tr><tr><td>Gender (% female)</td><td>43%</td><td>50%</td></tr></table> |
ec22d5dc75b0eb1fb2d34c4a067a256f14493f27e0e0fab9a407760cb2c20d66.png | simple | <table><tr><td>Line</td><td>Number of Individuals</td><td>Duplication</td><td>Deletion</td><td>HeR</td><td>Aneuploid</td><td>TOTAL</td></tr><tr><td>ACSRsyn1</td><td>16</td><td>2</td><td>2</td><td>0</td><td>0</td><td>4</td></tr><tr><td>Bronowski</td><td>16</td><td>0</td><td>1</td><td>0</td><td>0</td><td>1</td></tr><tr><... |
876b1fdc37c3bf2abfc002bb788be614702b140eb7fc7d6b28ababd9ff47f6ef.png | simple | <table><tr><td>Individual Outcome Variables</td><td>Time 1 INTMean (SD)</td><td>Time 2 INTMean (SD)</td><td>Time 1 CONMean (SD)</td><td>Time 2 CONMean (SD)</td></tr><tr><td>Girl's BMI</td><td>20.1 (4.4)</td><td>20.4 (4.5)</td><td>19.1 (2.9)</td><td>19.2 (3.0)</td></tr><tr><td>Girl's BMI percentile</td><td>65.2 (27.0)</... |
eedc88f0a223e44cb223b24650d7d02570b0a3f8abb7bcfa51b064c779203e7b.png | complex | <table><tr><td>Item</td><td> </td><td>Number</td><td>Percent</td><td>Adjusted OR*</td><td colspan="2">95% CI</td></tr><tr><td rowspan="2">A smoke-free hospital would improve the quality of care the patient receives (Agree)</td><td>Admin**</td><td>90</td><td>82.6%</td><td>1.0</td><td colspan="2"> </td></tr><tr><td>Physi... |
848465050c9d627e11296d2bab822761cdcac6af04020abf64de5b138ca00d48.png | simple | <table><tr><td>Rhomboid type</td><td>A Strepto</td><td>B Strepto</td><td>C Strepto</td><td>D Strepto</td><td>E Strepto</td><td>E Myco</td><td>AB Myco</td></tr><tr><td>A Strepto</td><td>–</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>B Strepto</td><td>0.29474</td><td>–</td><td></td><... |
bbbb71e1583056e83de623a58e73165820493461405f27c5ea339698f65d5eb0.png | simple | <table><tr><td>Cytokine</td><td>Total papers</td><td>Total ratios</td><td>References</td></tr><tr><td>IL-4</td><td>6</td><td>7</td><td>Hensley et al., 2002, 2003; Kim et al., 2006; Beers et al., 2008; Chiu et al., 2008; Audet et al., 2012</td></tr><tr><td>IL-6</td><td>8</td><td>12</td><td>Hensley et al., 2002, 2003; We... |
eb0ce2142d4ff4f4f633c9f8d8b211a16a767d5cd55852f6ca79d5dc0a80eb52.png | simple | <table><tr><td>Factor</td><td>Adjusted OR</td><td>95% CI</td><td><i>P</i> value</td></tr><tr><td>Age</td><td>1.032</td><td>0.991–1.075</td><td>0.129 (NS)</td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td></tr><tr><td> Female</td><td>1</td><td> </td><td> </td></tr><tr><td>Male</td><td>0.341</td><td>0.083&#... |
97f7136b647a387a41745ad46790b3b18e541fcc5db3c09bd232dff1c22e91d9.png | simple | <table><tr><td>Formulation (%)/treatment</td><td>T1</td><td>T2</td><td>T3</td></tr><tr><td>TV surimi</td><td>91.25</td><td>–</td><td>–</td></tr><tr><td>MSTM surimi</td><td>–</td><td>76.25</td><td>91.25</td></tr><tr><td>Cold water</td><td>–</td><td>15.00</td><td>–</td></tr><tr><td>Soybean-c... |
e33e7286d529a9efdc52c30a30ccefa1ef1d61a88d3d3227f1e8b032cdd58d00.png | simple | <table><tr><td>Dependent variable</td><td>Independent variable</td><td>Beta</td><td>95% CI</td><td>P</td></tr><tr><td>Physical functioning</td><td>Age</td><td>-7.49</td><td>-11.92-3.06</td><td>0.001</td></tr><tr><td></td><td>GHQ-28 score</td><td>-19.28</td><td>-27.21- -11.34</td><td>< 0.001</td></tr><tr><td></td><td... |
1e8ebde72423a6819b100f90301a4d6c34b6a6960fe0511defbf901484bca5b7.png | complex | <table><tr><td rowspan="2">N</td><td colspan="4">Multiplicative Model</td><td colspan="4">Additive Model</td></tr><tr><td>Coefficient</td><td>Value</td><td>SE</td><td>Units</td><td>Coefficient</td><td>Value</td><td>SE</td><td>Units</td></tr><tr><td>389</td><td>b *</td><td>0.0021</td><td>3.4 × 10<sup>−5</sup>... |
c17d4ac886ed525850cb270065af0b764cbeaf267edced847c0e94d45ecdf811.png | simple | <table><tr><td>Attribute</td><td>Value</td><td>% of Total</td></tr><tr><td>Genome size (bp)</td><td>4,024,382</td><td>100.00%</td></tr><tr><td>DNA coding region (bp)</td><td>3,618,708</td><td>89.92%</td></tr><tr><td>DNA G+C content (bp)</td><td>2,845,385</td><td>70.70%</td></tr><tr><td>Number of replicons</td><td>1</td... |
cb3627da7b7351e856a608c88ba9089a003bb261d5c9f2bd79af82554ec38398.png | simple | <table><tr><td> Group</td><td>Dose (mg/kg)</td><td>Sleep latency (min)</td><td>Sleeping time (min)</td></tr><tr><td>Normal</td><td>60</td><td>8 ± 1</td><td>36 ± 3</td></tr><tr><td> DZP</td><td> 3</td><td>6 ± 1*</td><td>75 ± 3*</td></tr><tr><td> ME</td><td> 800</td><td>12 ± 0.5*</td><td>45 ±... |
b8e140322d005a6f929f7851d68c36a37349106b45dc9f73a63ef2db8e95d3ea.png | complex | <table><tr><td></td><td colspan="2">Median (Inter-quartile range) or N (%)</td><td>*<i>p</i>-value</td></tr><tr><td>Variables</td><td>HCC (<i>n</i> = 62)</td><td>Non-HCC (<i>n</i> = 57)</td><td></td></tr><tr><td>Age (years)</td><td>49.5(35–55)</td><td>36(32–51)</td><td><i>p</i> = 0.05</td></tr><tr><td>Gende... |
4152468bdacc91c1c23edc2e9e096c7bdb3440387ac16182c5ddd66e6893f9e7.png | complex | <table><tr><td rowspan="2">Laboratorial Parameters</td><td colspan="2">Control Group <i>n</i> = 43</td><td colspan="2">SCD Groups <i>n</i> = 72</td><td rowspan="2"><i>p</i> Value</td></tr><tr><td>Median</td><td>IQR (P25–P75)</td><td>Median</td><td>IQR (P25–P75)</td></tr><tr><td>Hemoglobin (g/dL)</td><td>13.... |
b91816ce327c5833c7b59a9e4534686bfd8d01d511576d35dca5f006dabd04e5.png | complex | <table><tr><td>GO.ID</td><td>Term</td><td><i>p</i>-Value</td></tr><tr><td colspan="3">Topic 2</td></tr><tr><td>GO:0001054</td><td>RNA polymerase I activity</td><td>2.5e-07</td></tr><tr><td>GO:0043022</td><td>ribosome binding</td><td>4.8e-06</td></tr><tr><td>GO:0030515</td><td>snoRNA binding</td><td>5.0e-06</td></tr><tr... |
ec66f22823e49abe6469d8e2cda88dced04642fa64aa5fe0f604b5e186cede21.png | simple | <table><tr><td>Characteristics</td><td>Total (n, %)</td></tr><tr><td>Number</td><td>73</td></tr><tr><td>Age (years)</td><td>67.0 (SD 14.1)</td></tr><tr><td>Sex male</td><td>52 (71.2)</td></tr><tr><td>Admission NIHSS score</td><td>9.3 (SD 3.2)</td></tr><tr><td>Admission GCS score</td><td>5.6 (SD 2.0)</td></tr><tr><td>Sm... |
9e90d7611b1e3bce9709019a332e43fabadf47dd43f870820d58a19bb1be3809.png | complex | <table><tr><td rowspan="2">Indicator</td><td colspan="4">Baseline</td><td colspan="4">Follow-Up</td><td colspan="2">ATT</td></tr><tr><td>Control</td><td>Treated</td><td>Difference</td><td><i>p</i></td><td>Control</td><td>Treated</td><td>Difference</td><td><i>p</i></td><td>DID <sup>b</sup></td><td><i>p</i></td></tr><tr>... |
1ed7d3212d49aa8a1312321b9ef4beab2e290b67a22c4172a5b8f1b2e17830f4.png | simple | <table><tr><td>Hit rate (confirmed hits with selectivity over mammalian cell cytotoxicity)</td><td>G+ve</td><td>G-ve</td><td>Fungi</td></tr><tr><td>CO-ADD academic hit rate</td><td>0.66%</td><td>0.21%</td><td>0.98%</td></tr><tr><td>Commercial hit rate</td><td>0.03%</td><td>0.008%</td><td>ND</td></tr></table> |
fbba3d5d5b1d2966526cae14ba86eaa41e091773876983c614dfa33d1f34225b.png | complex | <table><tr><td>Treatment and Age Group<sup>a</sup></td><td>SPR, % (95% CI)</td><td>SCR, % (95% CI)</td><td>GMT, (95% CI)</td></tr><tr><td>LD HA/AS03<sub>B</sub></td><td></td><td></td><td></td></tr><tr><td> 18–40 y (n = 27)</td><td>96.3 (81.0–99.9)</td><td>96.3 (81.0–99.9)</td><td>98.3 (71.8–134.... |
01bac0ca8f9e874ab2e7bf12c2d34c18b05ad7dabad17b159ed95e65b6cc495b.png | simple | <table><tr><td>Molecular subtypes</td><td>Immunohistochemical characterization</td></tr><tr><td>Luminal A</td><td>ER + and/or PR+, HER2- CK8/18+</td></tr><tr><td>Luminal B</td><td>ER + and/or PR+, HER2+, CK8/18+</td></tr><tr><td>HER2+</td><td>ER-, PR-, HER2+</td></tr><tr><td>basal-like</td><td>ER-, PR-, HER2- and CK 5/... |
b71be187584ac83d3c423da14b5278a0efcfb16fd96be65594ddf964669b7d0e.png | complex | <table><tr><td rowspan="2">DNA adduct levels/HPV infection</td><td colspan="2">Protein expression</td><td rowspan="2"><i>p</i>-value</td></tr><tr><td>Negative (%)</td><td>Positive (%)</td></tr><tr><td>XRCC3</td><td></td><td></td><td></td></tr><tr><td> High/+ (n = 24)</td><td>15 (62.5)</td><td>9 (37.5)</td><td></td></tr... |
839023d39e8b88cc1d8ae5c582b3d5abbcbb7885ef666448be0fd884c9601e11.png | complex | <table><tr><td colspan="4">Control group</td></tr><tr><td>Score</td><td>2 weeks</td><td>14 weeks</td><td>26 weeks</td></tr><tr><td>Total</td><td>-0.06</td><td>-0.05</td><td>+0.01</td></tr><tr><td>Symptom domain</td><td>-0.21</td><td>-0.14</td><td>-0.11</td></tr><tr><td>Mental domain</td><td>0.0</td><td>0.0</td><td>0.0<... |
c2bf603ed62aca0c6d56da3508af403a613ff3aad5befaa57e1301a16826af63.png | complex | <table><tr><td rowspan="2">Jurisdiction</td><td rowspan="2">Health policy change in studied period</td><td colspan="2">Cost sharing mechanism</td><td rowspan="2">References</td></tr><tr><td>Outpatient/Inpatient services</td><td>Pharmaceuticals</td></tr><tr><td>1 Czech Rep</td><td>Introduction of formal fees</td><td>Unt... |
6ee04da386bcad4b5910ab687827d692058d757d9feb75f4b630f205f605e59e.png | simple | <table><tr><td>Data collection</td><td> </td></tr><tr><td>X-ray source</td><td>PF BL-5A</td></tr><tr><td>Wavelength (Å)</td><td>1.0000</td></tr><tr><td>Space group</td><td><i>P</i>4<sub>1</sub>2<sub>1</sub>2</td></tr><tr><td>Unit-cell parameters (Å)</td><td><i>a</i> = <i>b</i> = 91.3, <i>c</i> = 265.4</td><... |
76e2c526f5eab34dccd7f29c7f22acef4108444a174d4a6e2b952052d2f59149.png | complex | <table><tr><td>Step</td><td>Candidate genes</td><td>Wilks’ Lambda</td><td colspan="2">Exact F</td></tr><tr><td></td><td></td><td></td><td>Statistic</td><td>p value</td></tr><tr><td>1</td><td><i>TNFAIP3</i></td><td>0.404</td><td>59.002</td><td><0.001</td></tr><tr><td>2</td><td><i>IL-21</i></td><td>0.300</td><td... |
0f7cc8e3cfd204f41b7de2de6ad111ce592e9c914e30406f1c12fe52d86c9452.png | simple | <table><tr><td>Parameter</td><td><i>Model LR</i></td><td><i>AR(1)</i></td><td><i>AR(2)</i></td><td><i>AR(3)</i></td><td><i>AR(4)</i></td><td><i>AR(5)</i></td><td><i>Model LME</i></td></tr><tr><td><i>intercept</i></td><td>9.6448</td><td>9.6309</td><td>9.6441</td><td>9.6560</td><td>9.6617</td><td>9.6633</td><td>9.6719</t... |
ddc474bbfe00e11860ca6d8176b93295c7218040b27851ce09cdadc0144640f1.png | simple | <table><tr><td>Factors</td><td>Concepts</td><td>Health professionals’ experiences, barriers and facilitators & possible improvements with regard to:</td></tr><tr><td>Guideline related factors</td><td>Feasibility of the recommended guideline and the protocol derived from the guideline</td><td>- Guideline- Prot... |
08b9306c17b1574c3542909fecf2f17aa402f7157201a9fe915d170be70708d4.png | complex | <table><tr><td></td><td colspan="3">10-year breast cancer specific</td><td colspan="3">5-year BDDM</td></tr><tr><td>Variant</td><td><i>P</i>-value</td><td>HR</td><td>95% CI</td><td><i>P</i>-value</td><td>HR</td><td>95% CI</td></tr><tr><td>-903GA</td><td>0.01521</td><td>1.90</td><td>1.13 to 3.20</td><td>0.00201</td><td>... |
9befb659e4f5444ae687ee9b48b2b1898ff0f3b261ed0f952898cb8972832a2c.png | complex | <table><tr><td></td><td>moderate injury (<i>n</i> = 38)</td><td>severe injury (<i>n</i> = 63)</td><td>total (<i>n</i> = 101)</td><td>RTA (<i>n</i> = 68)</td><td>Fall (<i>n</i> = 24)</td></tr><tr><td colspan="6">Gender</td></tr><tr><td> Male (%)</td><td>31(82)</td><td>52(83)</td><td>83(82)</td><td>54(79)</td><td>22(92)<... |
1f0910bae552d8b93687e379f0a76aacda38b7f5a52a61b08c90099807ad3f1c.png | simple | <table><tr><td>DT sensitivity, <i>ψ</i></td><td>DT duration (days)</td><td>Total radiation (Gy)</td><td>TCP</td></tr><tr><td>5</td><td>238</td><td>76.84*</td><td>0.499</td></tr><tr><td></td><td>247</td><td>72.32*</td><td>0.505</td></tr><tr><td>50</td><td>204</td><td>74.58*</td><td>0.503</td></tr><tr><td></td><td>2... |
7b8305c270fe13ca141d052443e7ae0bce08c8e860eddda3c4abc1987f2f3551.png | simple | <table><tr><td>Variable</td><td>Group APioglitazone(n = 42)</td><td>Group BOther treatment(n = 39)</td><td>Pvalue</td></tr><tr><td>Age, years (range)</td><td>64.3 ± 8.1 (44-77)</td><td>64.8 ± 7.5 (48-81)</td><td>0.78</td></tr><tr><td>Female gender, n (%)</td><td>27 (64)</td><td>28 (72)</td><td>0.49</td></tr><... |
c48a9a079f4739c2a21f3545fe72c57cba4050ff9c49eac90a179a4864f9a5ad.png | simple | <table><tr><td> </td><td>Clonidine group </td><td>Clonidine and Dextromethorphan group</td><td><i>P</i> value</td></tr><tr><td>Number of patients </td><td>30</td><td>30</td><td>—</td></tr><tr><td>Initial symptoms score </td><td>2.7 ± 1.9</td><td>3.4 ± 2.6</td><td>0.17</td></tr><tr><td>Age </td><td>29.3 ... |
5afef5bc49b610bcfcc0ac3805b81db28ef66e9f04c8f314e7176473bfca59c6.png | simple | <table><tr><td> </td><td>FBP-OSEM</td><td>FBP-TOF</td><td>FBP-TPSF</td><td>OSEM-TOF</td><td>OSEM-TPSF</td><td>TOF-TPSF</td></tr><tr><td>2 min</td><td>0.40</td><td>0.74</td><td>0.64</td><td>0.53</td><td>0.64</td><td>0.87</td></tr><tr><td>5 min</td><td>0.34</td><td>0.66</td><td>0.55</td><td>0.59</td><td>0.71</td><td>0.87... |
ada5289422910ccc10af80923c345b991a42e6f2ea9dfb1905b3df22bd024154.png | complex | <table><tr><td></td><td>Active Synchronous</td><td>Passive Synchronous</td><td>Active Synchronous</td><td>Active Asynchronous</td></tr><tr><td></td><td>Congruent</td><td>Congruent</td><td>Incongruent</td><td>Congruent</td></tr><tr><td colspan="5">FMD group</td></tr><tr><td>Ownership statements vs. Ownership controls</t... |
2323a74239287f162092eb3b49322d3c5a23a0b3c0dfe03e0f42ee1d75359ee9.png | complex | <table><tr><td rowspan="2">Storage Condition (−80 °C)</td><td colspan="3">Fucoxanthin</td><td colspan="3">Fucoxanthinol</td></tr><tr><td>Concentration (ng/mL)</td><td>Accuracy (%)</td><td>RSD (%)</td><td>Concentration (ng/mL)</td><td>Accuracy (%)</td><td>RSD (%)</td></tr><tr><td rowspan="3">1 freeze-thaw cyc... |
79674d533fb8935f5b1355442473d297eb09350653091c764a1221c565145873.png | complex | <table><tr><td>Characteristic</td><td>Frequency</td><td>Percent</td><td>M (SD)</td><td>Range</td></tr><tr><td>Age</td><td></td><td></td><td>51.50 (14.56)</td><td>18–89</td></tr><tr><td>Duration of RD symptoms in years</td><td></td><td></td><td>18.84 (16.49)</td><td>0–75</td></tr><tr><td>Years since RD diagn... |
ee5d94776d6a6c2ea2ddf3aad8222d83064a19de617cc163df26bde844f9c431.png | simple | <table><tr><td> </td><td>Tumbi hospital (%)</td><td>Dodoma hospital (%)</td><td>All (%)</td></tr><tr><td>Occupational injury</td><td> </td><td> </td><td> </td></tr><tr><td>Needle stick (used needle)</td><td>64 (37.4)*</td><td>41 (17.8)</td><td>105 (26.2)</td></tr><tr><td>Blood stained sharp objects</td><td>64 (37.4)*</... |
06a7337dfe205cd42db4ca8020c4f76715abe975d6250ba3c3decde8e3c911c5.png | simple | <table><tr><td>Year</td><td>2010</td><td>2010</td></tr><tr><td>Group</td><td>BFM</td><td>Japanese Childhood AML Cooperative Study</td></tr><tr><td>Induction Therapy</td><td>ATRA+IDA+VP/CA+VP+DNR</td><td>ATRA+IDA+CA</td></tr><tr><td>No. of Pts</td><td>81</td><td>58</td></tr><tr><td>Consolidation Therapy</td><td>CA+IDA+H... |
2f6727286b8ea44c6df2062d865c8b28daa7652404cddac9a367ddc2eac8d7f7.png | complex | <table><tr><td rowspan="2">Size of facial image</td><td colspan="3">Size of LBP operator</td></tr><tr><td>3 × 3 operator</td><td>5 × 5 operator</td><td>7 × 7 operator</td></tr><tr><td>64 × 64</td><td>16.617</td><td>14.656</td><td>13.966</td></tr><tr><td>96 × 96</td><td>15.584</td><td>13.503</td... |
bbd7cbf39e0157bf7618d42a3b5af5562d592a71a48eac660426147fc31c7753.png | simple | <table><tr><td>Variables</td><td>Group C (<i>n</i> = 35)</td><td>Group T (n = 35)</td><td><i>P</i> value</td></tr><tr><td>Time from TAP to incision(min)</td><td>47.0(44.3–50.2)</td><td>46.9(43.5–47.8)</td><td>0.626</td></tr><tr><td>Incision length(cm)</td><td>30.0(23.8–35.0)</td><td>25.0(20.0–35... |
39e0023309ba90b5c9bedce1bc13e19f85e3d160a54d75aa60a05633d3e73ad7.png | complex | <table><tr><td rowspan="2">Fraction or COMBI</td><td colspan="3">Primary (% activity)</td><td colspan="4">Secondary (EC<sub>50</sub>, μg/mL)</td></tr><tr><td>μg/mL</td><td>MAR3D7<sup>a</sup></td><td>MARK1<sup>b</sup></td><td>HEK293<sup>c</sup></td><td>BJ<sup>d</sup></td><td>MAR3D7<sup>a</sup></td><td>MARK1<su... |
bb6747a6e8055e892746d51f04fdfe963f84ece34e447ee932b035db82e7e425.png | simple | <table><tr><td>Characteristic</td><td>mean ± SD, or N(%)</td></tr><tr><td>Gender</td><td> </td></tr><tr><td>Male</td><td>85 (38.3)</td></tr><tr><td>Female</td><td>137(61.7)</td></tr><tr><td>Marital status</td><td> </td></tr><tr><td>Married</td><td>205 (92.3)</td></tr><tr><td>Not married</td><td>17 (7.7)</td></tr><... |
813a43a82740c248777ece55eb64604c1e815879099c247fb129e92855edf10d.png | complex | <table><tr><td rowspan="2">Adsorbent</td><td rowspan="2">Concentration (mg/L)</td><td rowspan="2">q<sub>e(exp)</sub> (mg/g)</td><td colspan="3">Pseudo first order values</td><td colspan="4">Pseudo second order values</td></tr><tr><td>q<sub>e(Calc)</sub> (mg/g)</td><td>k<sub>1</sub> (min<sup>−1</sup>)</td><td>R<su... |
da964f1fcb6465bac93732b3c471f1a198e40aefcdc5ca9f91cca5ab873cc2b3.png | simple | <table><tr><td>Item</td><td>X<sub>1</sub> (h)</td><td>X<sub>2</sub> (°C)</td><td>X<sub>3</sub> (Ac:Al) a</td><td>X<sub>4</sub> (%)</td><td>Predicted yield (%)</td><td>Experimental yield (%)</td></tr><tr><td>Lipozyme<sup>®</sup> RMIM</td><td>4.00</td><td>57.51</td><td>2.12</td><td>46.41</td><td>97.56 ± 3.... |
a5649e5b1140cf6c25be4d68eb701ba537ddcdac9b6b0d1bb085e85310a68acd.png | complex | <table><tr><td>General recommendations</td><td>Rehabilitation should be undertaken by individuals with relevant skills and knowledge communication between teams and professionals over the rehabilitation pathway should occur</td></tr><tr><td>Pathway-specific recommendations</td><td> </td></tr><tr><td rowspan="5">During ... |
9534b6be11a8fe65016d58865f427986757de9dbb8abccc54ccea0ee16598428.png | simple | <table><tr><td>SNP-candidates</td><td>Morph</td><td>Uni</td><td>Rep</td><td>Total</td></tr><tr><td>Total</td><td></td><td>96231</td><td>74341</td><td>165790</td></tr><tr><td>Filter coverage</td><td></td><td>66569</td><td>57009</td><td>113776</td></tr><tr><td>Diff. Bwn. samples</td><td></td><td>21417</td><td>22252</td><... |
379b56c813922c1d3bc473188602b83215574eec46d4fdbed4b0ea262c848ccf.png | complex | <table><tr><td colspan="2">Variables</td><td>Frequency (percentage)</td></tr><tr><td colspan="2">Gender (females)</td><td>212 (58.1)</td></tr><tr><td colspan="2">Age at diagnosis (years):</td><td> </td></tr><tr><td> </td><td>≤ 5</td><td>24 (6.6)</td></tr><tr><td> </td><td>6–10</td><td>170 (46.6)</td></tr><t... |
0a7ad8b253b3a58b450c7b0142c33968d6dcc4876605c8248382f147ad4274f7.png | complex | <table><tr><td>Variable</td><td>Odds ratio</td><td colspan="2">95% confidence interval</td><td>Coefficient</td><td>S.E.</td><td>Significance</td></tr><tr><td colspan="7"><i>Predisposing</i></td></tr><tr><td colspan="7">Race/ethnicity (ref. = non-Hispanic White)</td></tr><tr><td> Black</td><td>1.738</td><td>1.371</td><t... |
2c4304bf21d681fde93952ffa07856f71c210489d1be3e3f6a250bfdc3f3ce2c.png | complex | <table><tr><td colspan="4">Method: 95% LSD</td></tr><tr><td>Pass</td><td>Count</td><td>LS Mean</td><td>Homogeneous Groups</td></tr><tr><td>0</td><td>21</td><td>1135.93</td><td>X</td></tr><tr><td>1</td><td>21</td><td>1245.32</td><td>X</td></tr><tr><td>2</td><td>21</td><td>1285.31</td><td>X</td></tr><tr><td>3</td><td>21<... |
b775f59626bd9ee98137c946d1f2dcd84e40c50941e355305d20fa52817db472.png | complex | <table><tr><td>Transgene</td><td>Description</td><td>Efficacy</td><td>Promoter</td><td>Assay</td><td>Publication</td></tr><tr><td>R2</td><td>SIV <i>rev</i> + <i>env</i> shRNA</td><td>68%–80% inhibition of viral replication</td><td>U6</td><td>SIV challenge, CEMx174 cell line</td><td>Park<i>et al</i>. 2005 [77]</td... |
665b222e5ce29ce8d06153ebb98450a337a05f0b6b032198767475a59e556cd6.png | complex | <table><tr><td>Characteristic*</td><td>Type 2 diabetes cases (n=1775)</td><td>Controls (n=1295)</td><td><i>p </i>value<sup>†</sup></td></tr><tr><td>Age (years)</td><td>65.8 (9.2)</td><td>65.7 (9.1)</td><td>0.93</td></tr><tr><td>Female, n (%)</td><td>1,014 (57)</td><td>731 (56)</td><td>0.71</td></tr><tr><td>BMI (k... |
8ac3c8856e73c997c6ac63e310bef0551b44b150792408e81759db3308fbc2fa.png | simple | <table><tr><td></td><td>ARVC Total (<i>N</i> = 155)</td><td>ECG-positive ARVC (<i>N</i> = 89)</td><td>ECG-negative ARVC (<i>N</i> = 66)</td><td><i>p</i>-valueECG-positive vs ECG-negative</td></tr><tr><td>Age</td><td>42.1 ± 17.3</td><td>42.0 ± 17.4</td><td>41.7 ± 17.6</td><td>0.861</td></tr><tr><td>Sex (%... |
584eb2a2a249dc3ddcf492f1361499cfa17e4035852b7a4287c4daade5fd9633.png | simple | <table><tr><td>Residue</td><td>W</td><td>Ac(%)</td><td>Sn(%)</td><td>Sp(%)</td><td>Mcc</td><td>FPR</td></tr><tr><td></td><td>7</td><td>74.94</td><td>51.80</td><td>87.33</td><td>0.43</td><td>0.13</td></tr><tr><td></td><td>9</td><td>75.02</td><td>52.17</td><td>87.26</td><td>0.44</td><td>0.13</td></tr><tr><td>S</td><td>11... |
79b854b71aae67297a9ef957ea4f20205bf0172f5a2940f40719e7472933923f.png | simple | <table><tr><td>Lesion</td><td>Age</td><td>Site</td><td>Cytomorphology</td><td>IHQ</td></tr><tr><td>Ganglioneuroma</td><td>80% < 10 years</td><td>Retroperitoneum, posterior mediastinum, pelvis, head and neck</td><td>Mature ganglion cells, myxoid stroma, schwann cells, neurites</td><td>NSE, Syp, PS-100 (+)CK, Actin (-... |
698fb31bd5a0e096bbd02c7605fd281d6386dbb02131369091e6b2395faa7bd0.png | simple | <table><tr><td>Professional category</td><td>Grade</td><td>Experience/ service</td><td>Annual salary prior to OSD</td><td>Annual salary as at 1 July 2009</td><td>Total annual salary package as at 1 July 2009*</td><td>% Increase Year 1</td><td>% Accumulative increase Year 2</td></tr><tr><td>Medical intern</td><td> </td>... |
b484c319c77770aa1360ac177667ea6f8af97513ad77364808da0095613b270b.png | simple | <table><tr><td>Time (week)</td><td>Body weight (kg)</td><td>TEE (kcal/day)</td><td>Mean energy intake (kcal/day)</td><td>Net energy intake (kcal/day)</td></tr><tr><td>0</td><td>69.39</td><td>1934.33</td><td>3538.72</td><td>1604.39</td></tr><tr><td>S1</td><td>68.35</td><td>1884.53</td><td>1658</td><td>−226.53</td>... |
282744cb84a1be8f7fbda241ac95872ff597f6b9d23c8020b8f2fda4ee79dde8.png | complex | <table><tr><td rowspan="2" colspan="2">Sliding window (SW)</td><td colspan="4">Most significant result</td></tr><tr><td colspan="4">HCV Genotype</td></tr><tr><td> </td><td> </td><td>1</td><td>2</td><td>1</td><td>2</td></tr><tr><td>SNPs/SW</td><td>No. of SW</td><td>SW</td><td>SW</td><td><i>P</i>value</td><td><i>P</i>val... |
95beac5f4d9ea484a4d8081533b327189338ba363e9da06f724e0065fb8478eb.png | simple | <table><tr><td></td><td>AP group</td><td>EP group</td></tr><tr><td>Number of patients</td><td>149</td><td>150</td></tr><tr><td>Sex</td><td></td><td></td></tr><tr><td> Male</td><td>114 (76.5 %)</td><td>113 (75.3 %)</td></tr><tr><td> Female</td><td>35 (23.5 %)</td><td>37 (24.7 %)</td></tr><tr><td>Median age, years (SD)<s... |
9270382416c13f914e3b852045dff07e1a69fd460280055e84f0adb7ffc368b6.png | simple | <table><tr><td><i>MicroRNA</i></td><td><i>No. of brain-expressed target genes</i></td><td><i>No. of brain-expressed target genes</i>, P<i><0.05</i></td><td><i>P enrichment</i></td><td><i>No. of significant targets (corr)</i></td><td><i>No. of significant pathways</i></td></tr><tr><td><i>miR-499-5p</i></td><td>286</t... |
ca9ac49a9a452888ca67da675e15ab60228634c4a8f6eb2d673b114cd1fce550.png | simple | <table><tr><td> </td><td>FEV1 loss < 15% (n = 28)</td><td>FEV1 loss ≥15% (n = 7)</td><td>p-value</td></tr><tr><td>Age</td><td>37 ± 13</td><td>45 ± 10</td><td>0.11</td></tr><tr><td>FEV1% pred.at T0</td><td>90 ± 17</td><td>98 ± 13</td><td>0.25</td></tr><tr><td>FEV1/FVC at T0</td><td>77 ±... |
f47eb13dde6b7be0eabcc647474ddc80860306b61516b8cd94e30a49971605a6.png | simple | <table><tr><td>Antigen</td><td>Labeled cells</td><td>Clone</td><td>Conjugate</td><td>Source<sup>a</sup></td></tr><tr><td>CD45</td><td>Pan-leukocyte</td><td>YKIX716.13</td><td>PE</td><td>AbD Serotec</td></tr><tr><td>CD18</td><td>Pan-leukocyte</td><td>CA1.4E9</td><td>AF647</td><td>AbD Serotec</td></tr><tr><td>CD3</td><td... |
44f6489546cca9d7418574b6be576d3b055854b503154b1f3e07f9a5651f2b5e.png | complex | <table><tr><td></td><td></td><td colspan="2">Results of conventional RT-PCR</td><td>Total</td></tr><tr><td></td><td></td><td>Positive</td><td>Negative</td><td></td></tr><tr><td>Results of NanoSign<sup>® </sup>Influenza A/B antigen kit</td><td>Positive</td><td>158</td><td>23</td><td>181</td></tr><tr><td></td><td>Ne... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.